Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

NCT07165951 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

566

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Pancreatic Ductal Adenocarcinoma

Interventions

DRUG: TQB2868 Injection
DRUG: Anlotinib Hydrochloride Capsules
DRUG: Gemcitabine Hydrochloride Injection
DRUG: Paclitaxel for Injection
DRUG: TQB2868 Placebo

Sponsor

Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.